Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAC1 | P63000 | 2/20 | 0.58 |
| ▸ | MAPT | P10636 | 1/20 | 0.58 |
| ▸ | KCNH3 | Q9ULD8 | 1/20 | 0.47 |
| ▸ | CCR4 | P51679 | 6/20 | 0.46 |
| ▸ | CACNA2D1 | P54289 | 4/20 | 0.43 |
| ▸ | TMEM97 | Q5BJF2 | 3/20 | 0.42 |
| ▸ | SIGMAR1 | Q99720 | 3/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3388177 | 0.89 | RAC1 (0.51) | RAC1MAPTKCNH3CCR4CACNA2D1 | |
| SCHEMBL3389936 | 0.74 | RAC1 (0.79) | RAC1MAPTKCNH3CCR4CACNA2D1 | |
| Hydrochloric Acid SCHEMBL3511071 | 0.74 | RAC1 (1.00) | RAC1MAPTKCNH3CCR4CACNA2D1 | |
| SCHEMBL2639296 | 0.72 | RAC1 (0.98) | RAC1MAPTKCNH3CCR4CACNA2D1 | |
| SCHEMBL3388954 | 0.72 | HTR1D (0.53) | RAC1MAPTCCR4LMNA | |
| SCHEMBL31379883 | 0.72 | HTR1A (0.49) | RAC1MAPTCCR4CACNA2D1 | |
| SCHEMBL3388179 | 0.72 | HTR1A (0.49) | RAC1MAPTCCR4CACNA2D1 | |
| SCHEMBL3392823 | 0.70 | MAPT (0.47) | RAC1MAPTKCNH3CCR4CACNA2D1 | |
| SCHEMBL3389537 | 0.70 | RAC1 (0.68) | RAC1MAPTKCNH3CCR4CACNA2D1 | |
| SCHEMBL3389160 | 0.69 | TSHR (0.48) | RAC1MAPTKCNH3CCR4CACNA2D1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2241555-A1 | New RAC1 inhibitors as potential pharmacological agents for heart failure treatment | UNIVERSITA' DEGLI STUDI DI MILANO (IT) | 2010-10-20 | — | — | EP | claimed |
| EP-2258370-A1 | Treatment of malignant diseases | Medizinische Universität Wien (AT) | 2010-12-08 | — | — | EP | disclosed |